Michael Albert, MD

24.4K posts

Michael Albert, MD banner
Michael Albert, MD

Michael Albert, MD

@MichaelAlbertMD

Physician | Co-Founder | Building the future of physician-owned healthcare at Vineyard

Here Katılım Haziran 2018
1.5K Takip Edilen20.8K Takipçiler
Sabitlenmiş Tweet
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
New chapter: I've joined Vineyard as Chief Medical Officer & Staff Physician. @DrNadolsky convinced me to help him build the future of physician-owned care—designed around both patients and physicians. After years in traditional healthcare, I'm not going back. Come work with me ⤵️ 🔗 joinvineyard.com/go/drmichaelal…
Michael Albert, MD tweet media
English
23
4
126
25.7K
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
Proud to see Vineyard expertise represented at #ACSM2026. Our own @AustinBaraki and @GrantTinsleyPhD are presenting on two topics that matter deeply to modern cardiometabolic care: resistance training and preserving muscle health during GLP-1 therapy.
Michael Albert, MD tweet media
English
0
2
9
1.1K
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
X TIPS: A hero tweet—the opening or index post of a thread—should be published as a standalone post, without external links. You can then reply to that hero tweet with the rest of the thread, including external links if needed, though X will reduce the visibility of posts containing outbound links. If the hero tweet does not contain links, people will still find the thread.
English
2
0
3
652
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
I've A/B tested this like crazy and it's real. X heavily suppresses posts with external links.
English
0
0
3
291
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
@DShaywitz @EvidenceOpen @EricTopol @askdrfatima @KevinH_PhD Yes—while not exclusive to this group, this sentiment is often associated with the “pull yourself up by your bootstraps” crowd: the same people who champion radical individual responsibility while supporting corporate welfare, tax breaks, and subsidies for large corporations.
English
1
0
1
194
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
@AKoutnik Hunger is not a pathology. I’m not sure what “eliminate hunger” even means, because hunger is a normal physiological response. I assume you’re using hunger as a surrogate for obesity, but even then, obesity is far more complex than simply a disorder of hunger.
English
0
0
1
54
Andrew Koutnik, Ph.D.
@MichaelAlbertMD Michael I can understand this based on what is out there ...but based on what I've seen in emergent agent...I disagree. The pharmacological game to eliminate hunger is going 200mph.
English
1
0
0
156
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
@AKoutnik Respectfully disagree. ASCVD pathophys is much better understood with far higher quality trials in much more diverse populations.
English
1
0
5
678
TARA Somerwil
TARA Somerwil@SomerwilTara·
@MichaelAlbertMD This reminds me 1971 and Richard Nixon when he said that by 1976 cancer will be cured. Wishful thinking or just naivety. 🤔 As a CV patient I keep my fingers crossed 🤞 I am remaining cautiously optimistic.
English
1
0
3
605
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
Thank you to all who have sacrificed—and continue to sacrifice—for our freedom, including several members of my family. 🙏🏻
English
0
0
3
387
Harold J. Burstein, MD, PhD, FASCO
One suspects that the issue here is that GLP1 agonists will help people’s overall survival, regardless, as to whether they have cancer. One is treating obesity, sleep apnea, diabetes, etc which probably make a difference for patients with cancer.
gilberto lopes@GlopesMd

GLP-1 RAs + Standard of Care Can Reduce Mortality Risk in HR-Positive, HER2-Negative Metastatic Breast Cancer dailynews.ascopubs.org/do/glp-1-recep… @OncoAlert @OncBrothers @StephenVLiu @Jani_Chinmay @asco @myESMO @glopesmd @SylvesterCancer @latinamd @iaslc @COlazagasti @JohnsHopkins @KimmelCancerCtr @OpenMedicineHQ

English
3
11
45
6.2K
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
@pranavvk I think cancer reduces when people are healthier. I'm not sure there's a unique drug effect in this regard.
English
0
0
0
19
Michael Albert, MD
Michael Albert, MD@MichaelAlbertMD·
With retatrutide approaching ~30% weight loss at 2 years—but with what appears to be a meaningfully higher adverse event burden than earlier-generation incretin therapies—expert clinical guidance will matter even more. If you thought the ED visits and poison control calls associated with the first wave of long-acting GLP-1s were concerning, wait until a far more potent therapy reaches broad scale without appropriate oversight. This is exactly why model matters. Vineyard is physician-led, expert obesity and cardiometabolic care. Our physicians are board-certified in obesity medicine, with additional board certifications across relevant specialties. If you’re going to use exceptionally powerful therapies, expertise matters. (Visual is illustrative only. Not an actual retatrutide product image.)
Michael Albert, MD tweet media
English
6
3
14
2.6K